Cargando…

Methadone and buprenorphine pharmacokinetics and pharmacodynamics when coadministered with fostemsavir to opioid‐dependent, human immunodeficiency virus seronegative participants

AIMS: Regional human immunodeficiency virus (HIV) prevalence rates are high in people with history of injection drug use, including those managed with maintenance opioids. Fostemsavir (FTR) is an oral prodrug of temsavir, a first‐in‐class attachment inhibitor that binds HIV‐1 gp120, preventing initi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Moore, Katy, Magee, Mindy, Sevinsky, Heather, Chang, Ming, Lubin, Susan, Myers, Elsa, Ackerman, Peter, Llamoso, Cyril
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2019
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6624406/ https://www.ncbi.nlm.nih.gov/pubmed/30980734 http://dx.doi.org/10.1111/bcp.13964

Ejemplares similares

Pharmacokinetics of Temsavir, the Active Moiety of the HIV-1 Attachment Inhibitor Prodrug, Fostemsavir, Coadministered with Cobicistat, Etravirine, Darunavir/Cobicistat, or Darunavir/Ritonavir with or without Etravirine in Healthy Participants
por: Moore, Katy, et al.
Publicado: (2022)

Pharmacokinetics of Temsavir, the Active Moiety of the Prodrug Fostemsavir, in Subjects with Hepatic Impairment
por: Sevinsky, Heather, et al.
Publicado: (2017)

Effects of Temsavir, Active Moiety of Antiretroviral Agent Fostemsavir, on QT Interval: Results From a Phase I Study and an Exposure–Response Analysis
por: Lagishetty, Chakradhar, et al.
Publicado: (2020)

2500. Fostemsavir Drug–Drug Interaction Profile, an Attachment Inhibitor and Oral Prodrug of Temsavir, for Heavily Treatment Experienced HIV-1-Infected Patients
por: Moore, Katy P, et al.
Publicado: (2019)

547. Results of Patient-Reported Outcome Data From the Phase III BRIGHTE Study of Fostemsavir
por: Proudfoot, Clare, et al.
Publicado: (2018)

Susceptibility of global HIV-1 clinical isolates to fostemsavir using the PhenoSense(®) Entry assay
por: Gartland, Margaret, et al.
Publicado: (2020)

1315. No Dose Adjustment of Metformin with Fostemsavir Coadministration Based on Mechanistic Static and Physiologically Based Pharmacokinetic Models
por: Nguyen, Dung N, et al.
Publicado: (2020)

Patient-Reported Outcomes in the Phase III BRIGHTE Trial of the HIV-1 Attachment Inhibitor Prodrug Fostemsavir in Heavily Treatment-Experienced Individuals
por: Anderson, Sarah-Jane, et al.
Publicado: (2021)

Buprenorphine‐naloxone, buprenorphine, and methadone throughout pregnancy in maternal opioid use disorder
por: Kanervo, Minna M., et al.
Publicado: (2022)

Long-term efficacy and safety of fostemsavir among subgroups of heavily treatment-experienced adults with HIV-1
por: Ackerman, Peter, et al.
Publicado: (2021)

Management of Opioid Addiction With Opioid Substitution Treatments: Beyond Methadone and Buprenorphine
por: Noble, Florence, et al.
Publicado: (2019)

Fostemsavir for HIV-1 infection
Publicado: (2022)

The Effects of Methadone and Buprenorphine on Testis of Rats
por: Corsi, Karen F.
Publicado: (2012)

Coadministered cannabidiol and clobazam: Preclinical evidence for both pharmacodynamic and pharmacokinetic interactions
por: Anderson, Lyndsey L., et al.
Publicado: (2019)

Opioid replacement therapy with methadone or buprenorphine effects on male mice reproduction
por: Moinaddini, Fatemeh, et al.
Publicado: (2022)

A Comparison of Buprenorphine + Naloxone to Buprenorphine and Methadone in the Treatment of Opioid Dependence during Pregnancy: Maternal and Neonatal Outcomes
por: Lund, Ingunn O., et al.
Publicado: (2013)

Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Coadministered Ruxolitinib and Artemether-Lumefantrine in Healthy Adults
por: Chughlay, M. Farouk, et al.
Publicado: (2022)

'Diversion’ of methadone or buprenorphine: 'harm’ versus 'helping’
por: Havnes, Ingrid Amalia, et al.
Publicado: (2013)

Comment on “A Comparison of Buprenorphine + Naloxone to Buprenorphine and Methadone in the Treatment of Opioid Dependence During Pregnancy: Maternal and Neonatal Outcomes”
por: Newman, Robert G., et al.
Publicado: (2013)

Comparing methadone and buprenorphine maintenance with methadone-assisted withdrawal for the treatment of opioid dependence during pregnancy: maternal and neonatal outcomes
por: Lund, Ingunn O, et al.
Publicado: (2012)

Methadone, Buprenorphine, and Street Drug Interactions with Antiretroviral Medications
por: Gruber, Valerie A., et al.
Publicado: (2010)

Methadone, Buprenorphine, and Clonidine Attenuate Mitragynine Withdrawal in Rats
por: Hassan, Rahimah, et al.
Publicado: (2021)

Demographic and Geospatial Analysis of Buprenorphine and Methadone Prescription Rates
por: Peterman, Nicholas J, et al.
Publicado: (2022)

The barriers to smoking cessation in Swiss methadone and buprenorphine-maintained patients
por: Wapf, Victoria, et al.
Publicado: (2008)

Neonatal outcomes following in utero exposure to buprenorphine/naloxone or methadone
por: Gawronski, Kristen M, et al.
Publicado: (2014)

Perioperative Management of Patients on Buprenorphine and Methadone: A Narrative Review
por: Sritapan, Yasmin, et al.
Publicado: (2020)

Prevalence and Characteristics of Chronic Pain in Buprenorphine and Methadone-Maintained Patients
por: Delorme, Jessica, et al.
Publicado: (2021)

Clinical Case Conference: Strategies for Transferring From Methadone to Buprenorphine
por: Hill, Duncan, et al.
Publicado: (2022)

Analytical Approaches for the Determination of Buprenorphine, Methadone and Their Metabolites in Biological Matrices
por: Shan, Xiaoyue, et al.
Publicado: (2022)

Prenatal Buprenorphine/Naloxone or Methadone Use on Neonatal Outcomes in Michigan
por: Goshgarian, Gregory, et al.
Publicado: (2022)

Methadone, Buprenorphine, Oxycodone, Fentanyl and Tramadol in Multiple Postmortem Matrices
por: Havig, Stine Marie, et al.
Publicado: (2021)

Patterns of non-compliant buprenorphine, levomethadone, and methadone use among opioid dependent persons in treatment
por: Casati, Alicia, et al.
Publicado: (2014)

Buprenorphine and Methadone as Opioid Maintenance Treatments for Heroin-Addicted Patients Induce Oxidative Stress in Blood
por: Leventelis, Christonikos, et al.
Publicado: (2019)

Cognitive functioning in opioid-dependent patients treated with buprenorphine, methadone, and other psychoactive medications: stability and correlates
por: Rapeli, Pekka, et al.
Publicado: (2011)

Characterizing opioid use disorder patients who have received medication trials with both buprenorphine and methadone
por: Wilder, Christine M, et al.
Publicado: (2015)

Metabolic and Addiction Indices in Patients on Opioid Agonist Medication-Assisted Treatment: A Comparison of Buprenorphine and Methadone
por: Elman, Igor, et al.
Publicado: (2020)

Hypogonadism and Low Testosterone Levels as a Side Effect of Methadone and Buprenorphine
por: Fareed, Ayman
Publicado: (2012)

Illicit use of methadone and buprenorphine among adolescents and young adults in Sweden
por: Richert, Torkel, et al.
Publicado: (2013)

Evaluation of drug-drug interaction between daclatasvir and methadone or buprenorphine/naloxone
por: Garimella, Tushar, et al.
Publicado: (2014)

Transferring Patients From Methadone to Buprenorphine: The Feasibility and Evaluation of Practice Guidelines
por: Lintzeris, Nicholas, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_123s2mi3svhmg6qa1jav1alle1